-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BMlNjZZ/MoKTtbMApbZu1yxXKyw0/uHurLokI3PLDQWar01slH9qO6/xWWSA+hwO Un7AbAOFFeasu1+Nz36CWg== 0000950144-05-000918.txt : 20050207 0000950144-05-000918.hdr.sgml : 20050207 20050207162238 ACCESSION NUMBER: 0000950144-05-000918 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050207 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050207 DATE AS OF CHANGE: 20050207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMSURG CORP CENTRAL INDEX KEY: 0000895930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621493316 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22217 FILM NUMBER: 05580756 BUSINESS ADDRESS: STREET 1: 20 BURTON HILLS BLVD STREET 2: STE 350 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 6156651283 MAIL ADDRESS: STREET 1: ONE BURTON HILLS BLVD. STREET 2: SUITE 350 CITY: NASHVILLE STATE: TN ZIP: 37215 8-K 1 g93098e8vk.htm AMSURG CORP. AMSURG CORP.
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 7, 2005 (February 7, 2005)

AMSURG CORP.

(Exact Name of Registrant as Specified in Charter)
         
Tennessee   000-22217   62-1493316
(State or Other Jurisdiction of   (Commission   (I.R.S. Employer
Incorporation)   File Number)   Identification No.)
     
20 Burton Hills Boulevard    
Nashville, Tennessee   37215
(Address of Principal Executive Offices)   (Zip Code)

(615) 665-1283
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     o Pre-commencement communications pursuant to Rule 13e-4(c) under th eExchange Act (17 CFR 240.13e-4(c))

 

TABLE OF CONTENTS

Item 7.01. Regulation FD Disclosure
Item 9.01. Financial Statements and Exhibits
SIGNATURES
INDEX TO EXHIBITS
EX-99 AMSURG CORP. TO PRESENT AT UBS GLOBAL HEALTHCARE SERVICES CONFERENCE

Table of Contents

Item 7.01. Regulation FD Disclosure

     On February 7, 2005, AmSurg Corp. issued a press release, the text of which is set forth as Exhibit 99.

Item 9.01. Financial Statements and Exhibits

     (c) 99 Press release dated February 7, 2005

2

Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  AMSURG CORP.
 		  
  By:   /s/ Claire M. Gulmi    
    Claire M. Gulmi   
    Senior Vice President and Chief Financial Officer
(Principal Financial and Duly Authorized Officer) 		  
 

Date: February 7, 2005

3

Table of Contents

INDEX TO EXHIBITS

         
Exhibit    
Number   Description
  99    
Press release dated February 7, 2005

4

EX-99 2 g93098exv99.txt EX-99 AMSURG CORP. TO PRESENT AT UBS GLOBAL HEALTHCARE SERVICES CONFERENCE EXHIBIT 99 PRESS RELEASE AMSURG CORP. TO PRESENT AT UBS GLOBAL HEALTHCARE SERVICES CONFERENCE ---------------------- LIVE PRESENTATION AND REPLAY AVAILABLE VIA THE INTERNET BEGINNING TUESDAY, FEBRUARY 15TH, AT 9:30 A.M. EASTERN NASHVILLE, Tenn. (Feb. 7, 2005) - AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the UBS Global Healthcare Services Conference, February 14th through February 16th in New York City. In connection with the conference, there will be an on-line simulcast and a replay of the Company's presentation available at the Company's web site starting at 9:30 a.m. Eastern on Tuesday, February 15, 2005. Claire M. Gulmi, Senior Vice President and Chief Financial Officer, will be speaking at the conference. The live audio Webcast and replay of the presentation will be available by going to www.amsurg.com. Please go to the site at least 15 minutes prior to the presentation to download and install any necessary audio software. AmSurg Corp. develops, acquires and manages physician practice-based ambulatory surgery centers in partnership with surgical and other group practices. At December 31, 2004, AmSurg owned a majority interest in 128 centers and had nine centers under development. Contact: Claire M. Gulmi Senior Vice President and Chief Financial Officer (615) 665-1283 -END- -----END PRIVACY-ENHANCED MESSAGE-----